Stock ALKS ALKERMES PLC
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Alkermes plc

Equities

ALKS

IE00B56GVS15

Real-time Estimate Cboe BZX
Other stock markets
 17:24:22 26/06/2024 BST 		5-day change 1st Jan Change
24.27 USD +0.37% Intraday chart for Alkermes plc -3.11% -12.51%
06-17 TD Cowen Initiates Alkermes at Buy With $34 Price Target MT
06-11 Transcript : Alkermes plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:40 AM

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alkermes to Participate in Two Upcoming Investor Conferences
PR
Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024
PR
Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk
PR
Alkermes : Q1 2024 Earnings Call Script FINAL 5 1 2024
PU
Alkermes : ALKS Q1 2024 Earnings Slides FINAL 5 1 2024
PU
Alkermes: Q1 Earnings Snapshot
AQ
Alkermes plc Reports First Quarter 2024 Financial Results
PR
Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1
PR
Alkermes to Report First Quarter Financial Results on May 1, 2024
PR
Alkermes Announces Positive Topline Results from Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients with Narcolepsy Type 2 and Idiopathic Hypersomnia
AQ
BlackBerry, Alkermes rise; Neogen, Tilray Brands fall, Tuesday, 4/9/2024
AQ
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
PR
Alkermes: Q4 Earnings Snapshot
AQ
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024
PR
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 15, 2024
PR
Alkermes Announces Topline Results from Long-Term, Open-Label Safety and Durability of Treatment Effect Study of LYBALVI
AQ
Alkermes to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PR
Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk
PR
Alkermes to Participate in Two Upcoming Investor Conferences
PR
Alkermes Completes Separation of Oncology Business
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALKS Stock
  4. News Alkermes plc
  5. Press Releases